Cargando…
Distinct expression pattern of the full set of secreted phospholipases A(2) in human colorectal adenocarcinomas: sPLA(2)-III as a biomarker candidate
Recent studies suggest that secreted phospholipases A(2) (sPLA(2)s) represent attractive potential tumour biomarkers and therapeutic targets for various cancers. As a first step to address this issue in human colorectal cancer, we examined the expression of the full set of sPLA(2)s in sporadic adeno...
Autores principales: | Mounier, C M, Wendum, D, Greenspan, E, Fléjou, J-F, Rosenberg, D W, Lambeau, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243149/ https://www.ncbi.nlm.nih.gov/pubmed/18212756 http://dx.doi.org/10.1038/sj.bjc.6604184 |
Ejemplares similares
-
Progranulin inhibits phospholipase sPLA2-IIA to control neuroinflammation
por: Du, Huan, et al.
Publicado: (2023) -
Discovery of AZD2716: A Novel Secreted Phospholipase
A(2) (sPLA(2)) Inhibitor for the Treatment of Coronary
Artery Disease
por: Giordanetto, Fabrizio, et al.
Publicado: (2016) -
Identification of a Dual Inhibitor of Secreted Phospholipase A(2) (GIIA sPLA(2)) and SARS-CoV-2 Main Protease
por: Theodoropoulou, Maria A., et al.
Publicado: (2022) -
The Roles of sPLA(2)s in Skin Homeostasis and Disease
por: Yamamoto, Kei, et al.
Publicado: (2023) -
sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor
por: Pan, Yangbin, et al.
Publicado: (2014)